MAPT and Alzheimer disease: Conversely, 78 proteins were significantly reduced in the CSF of the Aβ+/tau + AD patients compared to controls, including several immunoglobulins, SNRNP200, COL2A1, EPPK1, and others (Fig. 2A and supplemental Table S4).